We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

174 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 53 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $43.9M | Put options by funds: $18M

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

0% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 53

1% less funds holding

Funds holding: 175 → 174 (-1)

29% less capital invested

Capital invested by funds: $1.42B → $1.01B (-$408M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
174
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3.98%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
53
Reduced
53
Closed
24
Calls
$43.9M
Puts
$18M
Net Calls
+$25.9M
Net Calls Change
+$35.6M

Top Buyers

1
State Street
State Street
Massachusetts
+$21M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.7M
3
Renaissance Technologies
Renaissance Technologies
New York
+$15.3M
4
Bank of America
Bank of America
North Carolina
+$14.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$14.1M

Top Sellers

1
BlackRock
BlackRock
New York
-$26.4M
2
PHS
PFM Health Sciences
California
-$23.6M
3
SCM
Scopia Capital Management
New York
-$13.7M
4
Two Sigma Investments
Two Sigma Investments
New York
-$5.07M
5
BBA
Baker Bros. Advisors
New York
-$4.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$1.87M -$201K -65 -8%
PAM
52
Panagora Asset Management
Massachusetts
$1.85M -$1.75M -566 -42%
State of New Jersey Common Pension Fund D
53
State of New Jersey Common Pension Fund D
New Jersey
$1.77M – – –
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$1.76M +$467K +151 +25%
Man Group
55
Man Group
United Kingdom
$1.75M +$2.15M +696 +1,547%
Massachusetts Financial Services
56
Massachusetts Financial Services
Massachusetts
$1.69M +$743K +240 +51%
AA
57
ALPS Advisors
Colorado
$1.65M +$406K +131 +23%
Jane Street
58
Jane Street
New York
$1.53M +$2.01M +650 New
CS
59
Credit Suisse
Switzerland
$1.52M +$99.1K +32 +5%
AllianceBernstein
60
AllianceBernstein
Tennessee
$1.51M – – –
HSA
61
Hussman Strategic Advisors
Maryland
$1.47M – – –
SEI Investments
62
SEI Investments
Pennsylvania
$1.4M +$1.84M +595 +59,500%
Wells Fargo
63
Wells Fargo
California
$1.4M -$46.4K -15 -2%
PI
64
PineBridge Investments
New York
$1.32M -$322K -104 -16%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$1.31M – – –
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$1.29M +$1.7M +549 New
Swiss National Bank
67
Swiss National Bank
Switzerland
$1.28M – – –
GCP
68
GSA Capital Partners
United Kingdom
$1.2M +$1.57M +508 New
New York State Teachers Retirement System (NYSTRS)
69
New York State Teachers Retirement System (NYSTRS)
New York
$1.17M – – –
PP
70
PDT Partners
New York
$1.15M +$1.5M +486 New
ASRS
71
Arizona State Retirement System
Arizona
$1.12M -$294K -95 -17%
Mackenzie Financial
72
Mackenzie Financial
Ontario, Canada
$1.09M -$257K -83 -15%
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$1.07M – – –
CAM
74
ClariVest Asset Management
California
$1.04M -$37.1K -12 -3%
MCC
75
Malaga Cove Capital
California
$1.03M +$21.7K +7 +2%
1 2
3
4 5

ACOR Hedge Fund Activity: Q3 2018 in Review

174 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2018, worth a combined $1.01B — down 29% from $1.42B a quarter earlier.

Fund positioning in ACOR was balanced in Q3 2018: 24 funds opened new positions, 24 closed out, 53 added to existing stakes and 53 trimmed.

The largest buyer was State Street, adding an estimated $21M. The largest seller was BlackRock, cutting an estimated $26.4M.

  • 174 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2018, down from 175 in Q2 2018.
  • Funds reported $1.01B of Acorda Therapeutics stock for Q3 2018, down 29% quarter-over-quarter.
  • 24 funds opened new Acorda Therapeutics positions in Q3 2018 and 24 closed out, a net change of 0 holders.
  • The largest Acorda Therapeutics buyer in Q3 2018 was State Street, an estimated $21M added.
  • The largest Acorda Therapeutics seller in Q3 2018 was BlackRock, an estimated $26.4M sold.

Based on aggregated 13F filings for Q3 2018.